Indications

Trifibe SAP is a blend of three soluble, viscous fibers combined to reduce blood LDL and total cholesterol, and to improve insulin and glucose responses. Other health benefits of a soluble and viscous fiber blend include weight management, and improvement of gut regularity and health.

Ingredients

Each 10g contains:
Oat Fiber (22% β -glucan) 6.5 g
Psyllium Husk Powder 2.5 g
Glucomannan 1.0 g

Description

Effects of viscous fiber in the small intestine are thought to be due to its ability to increase the thickness of the unstirred water layer in the gut(18). Fiber is also associated with increased bile acid and lipid excretion, important in achieving total and LDL-cholesterol reduction(1). Fiber has been shown to produce short-chain fatty acids after intestinal fermentation of soluble fibers, a process that affects intestinal pH(1) and inhibits hepatic cholesterol synthesis(18).
Gastrointestinal Health, Irritable Bowel Syndrome, Diverticular Disease and Colon Cancer
The laxative effect of a fiber is related to its ability to increase fecal bulk and accelerate intestinal transit time. Although soluble and insoluble fibers both increase fecal mass, soluble fiber generally has a much lower fecal bulking effect of the two(18). Psyllium, however, is not well fermented by colonic microflora and does have a fecal bulking effect(18). In a recent meta-analysis of people suffering from irritable bowel syndrome (IBS), soluble fiber intake was linked with significant improvements in global symptoms and constipation related to IBS(19). Use of fiber in the treatment of uncomplicated diverticular disease is well established(1), however, the relief of symptoms appears greater with insoluble fiber types. While some arguments support the potential for highly fermentable soluble fiber intake to protect against colon cancer, controversy exists as to whether or not reduction of risk for development of this disease can be expected to occur(20).
Cardiovascular Disease
In contrast to water-insoluble fibers, most soluble fibers may lower plasma total cholesterol by a specific effect on LDL cholesterol, whereas HDL cholesterol or triglyceride concentrations are not generally affected. Increases in the amount of soluble fiber consumed correlate directly with the extent of reduction in blood lipids, and consumption of soluble, viscous fibers plays a role in reducing the risk of CHD by decreasing total and LDL cholesterol(18).
Diabetes
Soluble fiber intake has been associated with reduced glucose and insulin responses. These effects have been attributed to the fiber creating a gel-like substance in the stomach and thus delaying gastric emptying and absorption. It has also been suggested that consumption of soluble fiber speeds up intestinal transit allowing less time for carbohydrates to be absorbed in the upper jejunum, thus relieving insulin demand. Viscous fiber preparations have been used in the management of diabetes, as well as to reduce serum cholesterol levels in hyperlipidemia(18).

Quantity

30 sachets (Trifibe SAP-10)
340 g bottle (Trifibe SAP-340)

Dose

ADULT DOSAGE
1 sachet or 2 rounded Tbsp daily mixed well into 8 to 16 oz of fluid with or between meals or as directed by your physician.
Take one hour before or after other medications.

Each sachet or 2 Tbsp of Trifibe SAP is best taken with a minimum of 8 oz of fluid,
stirred well, and consumed soon after mixing followed by another 8 oz of water or juice. Not taking the adequate amounts of fluid may cause constipation.

Trifibe SAP-10 and Trifibe SAP-340 dissolves well in water. You can also try:
- Mixing it into a glass of orange juice or tomato juice.
- Stirring 1/2 of sachet or 1 Tbsp into a preheated bowl of vegetable soup (at least 8 oz of fluid).
- Adding 1/2 of sachet or 1 Tbsp to your oatmeal for breakfast (mix well). Drinking 1 to 2 cups of water with the oatmeal is encouraged.
- Blending it up with fruit and yogurt in a smoothie.
- Taking it mixed in fluid with a high glycemix index food to help keep your blood sugar from rising after eating.

Potential side effects/Safety

With intakes of oat, psyllium or glucomannan, some individuals have reported increases in flatulence. The Trifibe SAP-10 blend and doses of fibers have been selected to minimize bloating and flatulence that may be experienced after consuming higher doses of each of the three fiber types.

Attention: Always consume plenty of water daily while supplementing with dietary fiber. Initially, addition of dietary fiber may cause increased gas and bloating but these symptoms should decrease as the digestive system adjusts, which can take several days to two weeks. If you experience constipation, discontinue use for 3-5 days, then start at a low dose (i.e. 1/2 of previous daily dose) and gradually increase dosage while consuming plenty of water. To avoid any discomfort be sure to consume the suggested daily minimum of water (64 fluid ounces = 8 cups).

References

"Show references"

"Hide references"

1. Kay RM. J Lipid Res 1982;23:221-242.
2. Doi K. Eur J Clin Nutr 1995;49:S190-S197.
3. Truswell AS. Eur J Clin Nutr 2002;56:1-14.
4. Krauss RM, Eckel RH, Howard B, et al. Circulation 2000;102:2284-2299.
5. Kendall CW, Jenkins DJ. Curr Atheroscler Rep 2004;6:492-498.
6. Segasothy M, Phillips PA. QJM 1999;92:531-544.
7. Turconi G, Bazzano R, Caramella R, Lanzola E. Eur J Clin Nutr 1995;49:S312-S316.
8. Muller-Lissner SA. Br Med J (Clin Res Ed) 1988;296:615-617.
9. Anderson JW, Allgood LD, Lawrence A et al. Am J Clin Nutr 2000;71:472-479.
10. Chan EK, Schroeder DJ. Ann Pharmacother 1995;29:635-7.
11. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. Eur J Clin Nutr 2002;56:830-842.
12. Moreno LA, Tresaco B, Bueno G et al. J Physiol Biochem 2003;59:235-42.
13. Gonzalez Canga A, Fernandez Martinez N, Sahagun AM et al. Nutr Hosp 2004;19:45-50.
14. Vuksan V, Sievenpiper JL, Xu Z, Wong EY et al. J Am Coll Nutr 2001;20:370S-380S; discussion 381S-383S.
15. Walsh DE, Yaghoubian V, Behforooz A. Int J Obes 1984;8:289-293
16. Vuksan V, Sievenpiper JL, Owen R et al. Diabetes Care 2000;23:9-14.
17. Walsh DE, Yaghouubian V, Behforooz A. Int J Obes 1984;8:289-293.
18. Jenkins DJA, Wolever TMS, Jenkins AL. Modern Nutrition in Health and Disease. 9th Edition.
1999. pp.679-698.
19. Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, de Wit NJ. Aliment Pharmacol Therapy 2004;
19:245-251.
20. Lupton JR. Nutrition 2000;16:558-561.